COMP <GO>
MYE vs TMO // FORWARD P/E MULTIPLE
Myers Industries Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: MYE 5
— TMO 6
▲ FORWARD P/E MULTIPLE LEADER: MYE
LAST: $30.39 (-5.62%) • MKT CAP: $1.14B
forward-pe
30.4x
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
forward-pe
36.3x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MYE VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MYE | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 33.40% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 10.40% | 9.30% | +1.10 | MYE | /roic <GO> |
| EV/EBITDA & P/E Valuation | 15.5x | 30.4x | -14.90 | MYE | /valuation <GO> |
| Free Cash Flow Yield | 5.88% | 2.40% | +3.48 | MYE | /fcf-yield <GO> |
| Operating Margin | 9.00% | 17.40% | -8.40 | TMO | /operating-margins <GO> |
| Net Profit Margin | 4.20% | 15.10% | -10.90 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | -1.30% | 3.90% | -5.20 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.79% | 0.24% | +1.55 | MYE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.59 | 4.50 | -1.91 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 35.9 | 62.9 | -27.00 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 30.4x | 36.3x | -5.90 | MYE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.14B | $262.22B | -$261.07B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MYE REV | TMO REV | MYE GROSS % | TMO GROSS % | MYE FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $825.7M | $44.56B | 33.4% | — | $67.2M | $6.29B |
| FY 2024 | $836.3M | $42.88B | 32.4% | — | $54.9M | $7.27B |
| FY 2023 | $813.1M | $42.86B | — | — | $86.2M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MYE // BETA —
TMO // BETA 0.94